| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/28/2023 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 2.3k | $8.85 | $20k | | 02/28/2023 |
| 12/16/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 9.4k | $1.50 | $14.1k | | 12/16/2022 |
| 11/30/2022 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 1.5k | $13.36 | $20k | | 11/30/2022 |
| 09/16/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 6.6k | $2.62 | $17.3k | | 09/16/2022 |
| 08/31/2022 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 1.4k | $13.90 | $20k | | 08/31/2022 |
| 06/17/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 8.5k | $2.03 | $17.3k | | 06/17/2022 |
| 06/10/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 06/10/2022 |
| 06/07/2022 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | Common Stock | 12.9k | $0.00 | $0 | | 06/07/2022 |
| 06/07/2022 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 30k | $10.79 | $323.9k | | 06/07/2022 |
| 05/31/2022 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 2.1k | $9.31 | $19.3k | | 05/31/2022 |
| 03/18/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 5.8k | $3.02 | $17.5k | | 03/18/2022 |
| 02/28/2022 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 1.1k | $16.61 | $18.7k | | 02/28/2022 |
| 12/17/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 3.3k | $5.31 | $17.5k | | 12/17/2021 |
| 11/30/2021 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 1.6k | $12.06 | $18.7k | | 11/30/2021 |
| 09/17/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 1.9k | $9.90 | $18.5k | | 09/17/2021 |
| 08/31/2021 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 1.2k | $15.92 | $18.7k | | 08/31/2021 |
| 06/18/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $12.55 | $188.2k | | 06/18/2021 |
| 06/18/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 1.3k | $12.95 | $16.3k | | 06/18/2021 |
| 05/28/2021 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 1.2k | $15.77 | $18.7k | | 05/28/2021 |
| 05/25/2021 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 40k | $13.28 | $531.2k | | 05/25/2021 |
| 03/18/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 677 | $24.01 | $16.3k | | 03/18/2021 |
| 02/26/2021 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 1.7k | $10.78 | $18.7k | | 02/26/2021 |
| 12/15/2020 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 505 | $34.29 | $17.3k | | 12/15/2020 |
| 11/30/2020 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 3.7k | $5.11 | $18.7k | | 11/30/2020 |
| 09/30/2020 | Black Diamond Therapeutics, Inc. | BDTX | Purchase | Common Stock | 5k | $30.46 | $152.3k | | 09/30/2020 |
| 09/25/2020 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 29.8k | $29.65 | $884.8k | | 09/25/2020 |
| 08/31/2020 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 4.5k | $4.15 | $18.7k | | 08/31/2020 |
| 07/28/2020 | Novan, Inc. | NOVN | Grant | Stock Option (Right to Buy) | 20k | $0.78 | $15.6k | | 07/28/2020 |
| 06/01/2020 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 4.2k | $4.50 | $18.7k | | 06/01/2020 |
| 05/12/2020 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 40k | $5.41 | $216.4k | | 05/12/2020 |
| 03/01/2020 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 6.2k | $3.00 | $18.8k | | 03/01/2020 |
| 12/01/2019 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 6.6k | $2.85 | $18.7k | | 12/01/2019 |
| 11/18/2019 | BIOCRYST PHARMACEUTICALS INC | BCRX | Purchase | Common Stock | 20k | $1.45 | $29k | | 11/18/2019 |
| 09/01/2019 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 6.3k | $2.99 | $18.7k | | 09/01/2019 |
| 07/31/2019 | Novan, Inc. | NOVN | Grant | Stock Option (Right to Buy) | 20k | $2.63 | $52.6k | | 07/31/2019 |
|